MegaScreen

The value of tumor cell lines, as research models and drug discovery tools, is greatly enhanced when there is an understanding of the underlying genetic abnormalities that drive their phenotype. Equipped with over 700 authenticated reliable human cancer cell lines, Kyinno provides customized cell panel studies to facilitate your drug discovery and biomarker programs.

Case study: HRD high score cell panel screening
HRD Homologous recombination deficiency (HRD) score of the cell lines was calculated and hundreds of cell lines with high HRD score were selected for compound screening. In a 14 days compound treatment assay, 4 compounds’ test were successfully delivered within 4 weeks.